Dolby Laboratories $DLB Shares Purchased by Vest Financial LLC

Vest Financial LLC raised its holdings in Dolby Laboratories (NYSE:DLB – Free Report) by 9.9% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 136,282 shares of the electronics maker’s stock after acquiring an additional 12,303 shares during the quarter. Vest Financial LLC owned about 0.15% of Dolby Laboratories worth $8,009,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the business. Bank of New York Mellon Corp acquired a new position in shares of Dolby Laboratories during the 2nd quarter worth $253,289,000. First Trust Advisors LP lifted its stake in shares of Dolby Laboratories by 19.9% in the 1st quarter. First Trust Advisors LP now owns 2,254,933 shares of the electronics maker’s stock valued at $135,431,000 after purchasing an additional 374,405 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in shares of Dolby Laboratories by 507.5% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 124,509 shares of the electronics maker’s stock valued at $7,478,000 after purchasing an additional 104,014 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of Dolby Laboratories by 6.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,321,407 shares of the electronics maker’s stock valued at $79,357,000 after purchasing an additional 83,835 shares during the last quarter. Finally, Sei Investments Co. boosted its holdings in Dolby Laboratories by 26.4% in the first quarter. Sei Investments Co. now owns 308,307 shares of the electronics maker’s stock worth $18,516,000 after purchasing an additional 64,306 shares in the last quarter. 58.56% of the stock is owned by institutional investors.

Dolby Laboratories Stock Up 1.2%

Shares of DLB stock opened at $63.24 on Friday. Dolby Laboratories has a 12 month low of $48.26 and a 12 month high of $69.95. The business’s 50 day moving average is $60.75 and its two-hundred day moving average is $57.61. The company has a market cap of $5.92 billion, a PE ratio of 26.91 and a beta of 0.78.

Dolby Laboratories (NYSE:DLB – Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The electronics maker reported $0.69 EPS for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.08%. The company had revenue of $305.00 million for the quarter, compared to analyst estimates of $311.96 million. During the same quarter last year, the firm posted $0.78 earnings per share. The company’s quarterly revenue was down 3.3% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. As a group, equities analysts expect that Dolby Laboratories will post 3.23 EPS for the current fiscal year.

Dolby Laboratories Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, August 19th. Investors of record on Tuesday, August 11th were paid a $0.36 dividend. The ex-dividend date was Tuesday, August 11th. This represents a $1.44 dividend on an annualized basis and a yield of 2.3%. Dolby Laboratories’s dividend payout ratio (DPR) is presently 61.28%.

Dolby Laboratories declared that its board has approved a share repurchase program on Thursday, July 30th that allows the company to buy back $350.00 million in shares. This repurchase authorization allows the electronics maker to purchase up to 7% of its shares through open market purchases. Stock repurchase programs are generally an indication that the company’s leadership believes its stock is undervalued.

Analyst Ratings Changes

Several equities analysts have commented on DLB shares. Wall Street Zen downgraded shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Weiss Ratings upgraded Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, September 9th. Zacks Research cut Dolby Laboratories from a “hold” rating to a “strong sell” rating in a research report on Thursday, October 15th. Finally, Rosenblatt Securities reiterated a “buy” rating and set a $85.00 price target on shares of Dolby Laboratories in a research note on Friday, August 28th. Two equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $87.50.

Check Out Our Latest Research Report on Dolby Laboratories

Insider Activity at Dolby Laboratories

In other Dolby Laboratories news, CAO Ryan Nicholson sold 1,348 shares of the business’s stock in a transaction on Monday, August 10th. The shares were sold at an average price of $62.04, for a total transaction of $83,629.92. Following the completion of the transaction, the chief accounting officer owned 35,636 shares of the company’s stock, valued at $2,210,857.44. The trade was a 3.64% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP John D. Couling sold 7,667 shares of the business’s stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $60.00, for a total transaction of $460,020.00. Following the transaction, the senior vice president directly owned 118,727 shares of the company’s stock, valued at approximately $7,123,620. This represents a 6.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 28,889 shares of company stock worth $1,749,388. 37.93% of the stock is owned by insiders.

About Dolby Laboratories

(Free Report)

Dolby Laboratories, Inc develops audio and imaging technologies used to enhance entertainment and communications experiences. The company’s technologies are incorporated into cinema, television, broadcast, streaming, mobile, personal computer, automotive and gaming products and services.

Its principal offerings include Dolby Atmos, an object-based audio technology designed to create immersive sound, and Dolby Vision, a high-dynamic-range imaging technology intended to improve picture quality.

See Also

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.